Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report) was the target of a large decrease in short interest in July. As of July 31st, there was short interest totaling 27,548,732 shares, a decrease of 49.2% from the July 15th total of 54,218,169 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days. Approximately 0.1% of the company’s stock are sold short.
Sino Biopharmaceutical Stock Performance
Shares of OTCMKTS:SBMFF opened at $0.61 on Friday. The company’s fifty day moving average price is $0.62 and its 200 day moving average price is $0.72. Sino Biopharmaceutical has a 12 month low of $0.59 and a 12 month high of $1.24.
About Sino Biopharmaceutical
Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.
The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.
Featured Stories
- Five stocks we like better than Sino Biopharmaceutical
- Microsoft’s Maia 300 Chip Targets NVIDIA’s AI Dominance
- 3 Unexpected ETFs Crushing the Market This Summer
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
